Discontinuation report CLINIMIX E

Last updated on 2020-06-22 History
Report ID 118604
Drug Identification Number 02014068
Brand name CLINIMIX E
Common or Proper name CLINIMIX E
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) TRYPTOPHAN L-PROLINE L-TYROSINE POTASSIUM PHOSPHATE DIBASIC SODIUM CHLORIDE MAGNESIUM CHLORIDE SODIUM ACETATE DEXTROSE L-LEUCINE HYDROCHLORIDE L-PHENYLALANINE HYDROCHLORIDE L-LYSINE HYDROCHLORIDE METHIONINE L-ALANINE GLYCINE L-ARGININE L-ISOLEUCINE L-VALINE HISTIDINE L-THREONINE
Strength(s) 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 500mL (JB6763)
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-03-19
Actual discontinuation date
Remaining supply date 2021-03-19
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Please refer to customer communication dated June 22, 2020 for a complete list of products being discontinued and CLINIMIX products remaining in the market. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information. For ordering support of any of our products, please contact Baxter Customer Service at 1-888-719-9955.
Health Canada comments
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-06-22 French Compare
v1 2020-06-22 English Compare